Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + Tamoxifen in First-Line Metastatic HR+/HER2- Breast Cancer
NCT02668666Phase 2Completed
- Sponsor
- Oana Danciu
- Start
- Feb 2017
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Oana Danciu. Started Feb 2017; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02668666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668666.